64 results
6-K
EX-99.1
BLU
Bellus Health Inc
28 Jun 23
GSK completes acquisition of BELLUS Health
11:05am
of BELLUS is highly synergistic with GSK’s expertise in respiratory medicines and is further supported by GSK’s leading R&D, manufacturing
6-K
EX-99.1
BLU
Bellus Health Inc
2 Jun 23
Notice of Annual and Special Meeting of Shareholders
4:25pm
, United States
Executive Vice President, Head of R&D and Chief Medical Officer of CSL Behring (10)
Director
NIL
Joseph Rus (5), (7)
Toronto
6-K
EX-99.2
BLU
Bellus Health Inc
12 May 23
Condensed Consolidated Interim Financial Statements of
4:32pm
external R&D expenses incurred for the development of camlipixant, mainly for activities in relation to our CALM Phase 3 clinical program, which
6-K
EX-99.1
BLU
Bellus Health Inc
12 May 23
BELLUS Health Reports First Quarter 2023 Financial Results and Business Highlights
4:02pm
increase. The increase is primarily attributable to higher external R&D spend incurred for the development of camlipixant, mainly for activities
6-K
EX-99.1
BLU
Bellus Health Inc
18 Apr 23
GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health
6:02am
and is further supported by GSK’s leading R&D, manufacturing, and commercialisation capabilities.
Following the anticipated regulatory approval and launch
6-K
EX-99.2
pgfp8ed b1b3aemgsbhd
30 Mar 23
Notice of Annual and Special Meeting of Shareholders
11:22am
6-K
EX-99.1
wkl8e2fv c46
29 Mar 23
Current report (foreign)
5:26pm
6-K
EX-99.2
2z5sw
14 Nov 22
Condensed Consolidated Interim Financial Statements of
5:26pm
6-K
EX-99.1
vah69a
14 Nov 22
BELLUS Health Reports Third Quarter 2022 Financial Results and Business Highlights
4:03pm
6-K
EX-99.2
dk2zo
10 Aug 22
Condensed Consolidated Interim Financial Statements of
4:56pm
6-K
EX-99.1
hd0bn difgg
10 Aug 22
BELLUS Health Reports Second Quarter 2022 Financial Results and Business Highlights
4:31pm
6-K
EX-99.1
r8tqqsgj2iz7vpg
11 May 22
BELLUS Health Reports First Quarter 2022 Financial Results and Business Highlights
5:23pm
6-K
EX-99.2
yo56t98vgp7p01a
11 May 22
Condensed Consolidated Interim Financial Statements of
5:05pm
6-K
EX-99.2
uzu 9y3ntd8
7 Apr 22
Notice of Annual Meeting of Shareholders
9:01am
40-F
EX-99.1
x16elv3njzyzo qex
23 Feb 22
Annual report (Canada)
5:20pm
6-K
EX-99.2
fkm1iuy2m5 0n
9 Apr 21
Notice of Annual Meeting of Shareholders
12:00am
6-K
EX-99.1
3nd6qfzd j8vaai
8 Apr 21
Bellus HEALTH 2020 ANNUAL REPORT
10:16am
40-F
EX-99.1
f5uez6n
25 Feb 21
Annual report (Canada)
4:58pm
40-F
EX-99.3
ut6ai573x6mpbo
25 Feb 21
Annual report (Canada)
4:58pm
6-K
EX-99.1
pexzekxflr6te8
7 Dec 20
Bellus Health Inc. 6-K
7:01am